Tubulis Technologies
PrivateLast Round
Series C
10/30/2025
Total Funding Raised
$615.1M
Momentum Score
50 /100
Company Overview
Tubulis Technologies is a biotechnology company developing antibody-drug conjugates (ADCs) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tubulis Technologies Comps
Public and private peers based on sector, stage, and business model.
Tubulis Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | 10/30/2025 | ||||
| Series B Extension | 3/14/2024 | ||||
| Series B | 5/3/2022 | ||||
| Series A | 7/21/2020 |
Key People
Founding team and executive leadership
Tubulis Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| BioMedPartners | Series B Extension, Series A, Series B |
| EQT Life Sciences | Series C, Series B Extension |
| Fund+ | Series B Extension, Series B, Series C |
| Andera Partners | Series B Extension, Series C, Series B |
| Fidelity Management & Research Company | Series C |
| Deep Track Capital | Series B Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
P5 technology further developed for clinical research with Ludwig Maximilian University.
- Apr 7, 2026
Partnering with Ludwig Maximilian University on P5 technology development.
Tubulis Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tubulis Technologies's valuation, stock price, and market status.
